TANDEM DIABETES CARE INC (TNDM)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for TNDM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TNDM | Chief Product Officer | 49 | ["Over 20 years of global experience across the healthcare value chain","Chief Product Officer at Verily","President and Chief Strategy Officer at Carbon Health","Head of Health Strategic Initiatives at Apple","Principal and Co-Leader of the West Coast Strategy and Corporate Finance Practice at McKinsey & Company","JD from Harvard Law School","MBA from Harvard Business School","AB in Biochemical Sciences from Harvard College"] | ["Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Cha has served on our board of directors since June 2022. He has more than 20 years of global experience across the healthcare value chain. Mr. Cha currently serves as Chief Product Officer at Verily where he leads product development. Before joining Verily in March 2024, he served as President and Chief Strategy Officer at Carbon Health from June 2021 to February 2024. He served as Head of Health Strategic Initiatives at Apple from August 2015 to May 2021 where he developed and led product initiatives and global strategic partnerships. Earlier in his career, Mr. Cha was a Principal and Co-Leader of the West Coast Strategy and Corporate Finance Practice as well as Co-Leader of the Healthcare Investor Practice at McKinsey & Company. Mr. Cha holds a JD from Harvard Law School, an MBA from Harvard Business School and an AB in Biochemical Sciences from Harvard College. We believe Mr. Cha s experience as a healthcare and consumer technology executive developing and leading global and strategic initiatives and partnerships, while maximizing the value of data and using analytics to drive enhanced customer experiences and better clinical outcomes, brings to the Board critical skills related to advancing the Company s ecosystem of data-driven products and services, which qualify him to serve as one of the Company s directors.